Characterization of the rotenone mouse model of Parkinson's disease using radioligands for the adenosine A2A receptor ([F-18] FESCH) and the nicotinic alpha 4 beta 2 receptor ((-)-[F-18] Flubatine). Toussaint, M., Kranz, M., Schroeder, S., Lai, T. H., Deuther-Conrad, W., Dukic-Stefanovic, S., Shang, Q., Patt, M., Reichmann, H., & Funk, R. Journal of Labelled Compounds & Radiopharmaceuticals, 62:S397–S398, 2019. bibtex @article{toussaint_characterization_2019,
Author = {Toussaint, Magali and Kranz, Mathias and Schroeder, Susann and Lai, Thu Hang and Deuther-Conrad, Winnie and Dukic-Stefanovic, Sladjana and Shang, Qi and Patt, Marianne and Reichmann, Heinz and Funk, Richard},
Journal = {Journal of Labelled Compounds \& Radiopharmaceuticals},
Pages = {S397--S398},
Title = {Characterization of the rotenone mouse model of {Parkinson}'s disease using radioligands for the adenosine {A}2A receptor ([{F}-18] {FESCH}) and the nicotinic alpha 4 beta 2 receptor ((-)-[{F}-18] {Flubatine})},
Volume = {62},
Year = {2019}}
Downloads: 0
{"_id":"fpRXbKhc4NaxR2bNv","bibbaseid":"toussaint-kranz-schroeder-lai-deutherconrad-dukicstefanovic-shang-patt-etal-characterizationoftherotenonemousemodelofparkinsonsdiseaseusingradioligandsfortheadenosinea2areceptorf18feschandthenicotinicalpha4beta2receptorf18flubatine-2019","authorIDs":[],"author_short":["Toussaint, M.","Kranz, M.","Schroeder, S.","Lai, T. H.","Deuther-Conrad, W.","Dukic-Stefanovic, S.","Shang, Q.","Patt, M.","Reichmann, H.","Funk, R."],"bibdata":{"bibtype":"article","type":"article","author":[{"propositions":[],"lastnames":["Toussaint"],"firstnames":["Magali"],"suffixes":[]},{"propositions":[],"lastnames":["Kranz"],"firstnames":["Mathias"],"suffixes":[]},{"propositions":[],"lastnames":["Schroeder"],"firstnames":["Susann"],"suffixes":[]},{"propositions":[],"lastnames":["Lai"],"firstnames":["Thu","Hang"],"suffixes":[]},{"propositions":[],"lastnames":["Deuther-Conrad"],"firstnames":["Winnie"],"suffixes":[]},{"propositions":[],"lastnames":["Dukic-Stefanovic"],"firstnames":["Sladjana"],"suffixes":[]},{"propositions":[],"lastnames":["Shang"],"firstnames":["Qi"],"suffixes":[]},{"propositions":[],"lastnames":["Patt"],"firstnames":["Marianne"],"suffixes":[]},{"propositions":[],"lastnames":["Reichmann"],"firstnames":["Heinz"],"suffixes":[]},{"propositions":[],"lastnames":["Funk"],"firstnames":["Richard"],"suffixes":[]}],"journal":"Journal of Labelled Compounds & Radiopharmaceuticals","pages":"S397–S398","title":"Characterization of the rotenone mouse model of Parkinson's disease using radioligands for the adenosine A2A receptor ([F-18] FESCH) and the nicotinic alpha 4 beta 2 receptor ((-)-[F-18] Flubatine)","volume":"62","year":"2019","bibtex":"@article{toussaint_characterization_2019,\n\tAuthor = {Toussaint, Magali and Kranz, Mathias and Schroeder, Susann and Lai, Thu Hang and Deuther-Conrad, Winnie and Dukic-Stefanovic, Sladjana and Shang, Qi and Patt, Marianne and Reichmann, Heinz and Funk, Richard},\n\tJournal = {Journal of Labelled Compounds \\& Radiopharmaceuticals},\n\tPages = {S397--S398},\n\tTitle = {Characterization of the rotenone mouse model of {Parkinson}'s disease using radioligands for the adenosine {A}2A receptor ([{F}-18] {FESCH}) and the nicotinic alpha 4 beta 2 receptor ((-)-[{F}-18] {Flubatine})},\n\tVolume = {62},\n\tYear = {2019}}\n\n","author_short":["Toussaint, M.","Kranz, M.","Schroeder, S.","Lai, T. H.","Deuther-Conrad, W.","Dukic-Stefanovic, S.","Shang, Q.","Patt, M.","Reichmann, H.","Funk, R."],"key":"toussaint_characterization_2019","id":"toussaint_characterization_2019","bibbaseid":"toussaint-kranz-schroeder-lai-deutherconrad-dukicstefanovic-shang-patt-etal-characterizationoftherotenonemousemodelofparkinsonsdiseaseusingradioligandsfortheadenosinea2areceptorf18feschandthenicotinicalpha4beta2receptorf18flubatine-2019","role":"author","urls":{},"metadata":{"authorlinks":{}},"downloads":0},"bibtype":"article","biburl":"https://drive.google.com/uc?id=1npQd_kFQJ1WhoHFdMxm9f24VTXXUJ6kw","creationDate":"2020-12-19T04:09:57.930Z","downloads":0,"keywords":[],"search_terms":["characterization","rotenone","mouse","model","parkinson","disease","using","radioligands","adenosine","a2a","receptor","fesch","nicotinic","alpha","beta","receptor","flubatine","toussaint","kranz","schroeder","lai","deuther-conrad","dukic-stefanovic","shang","patt","reichmann","funk"],"title":"Characterization of the rotenone mouse model of Parkinson's disease using radioligands for the adenosine A2A receptor ([F-18] FESCH) and the nicotinic alpha 4 beta 2 receptor ((-)-[F-18] Flubatine)","year":2019,"dataSources":["oPYGjz5LJw7BLCPiK","c6fLyraeGp89Bmhyo","qb42Xqdsuo5n9MtiJ","3HekLNYCKYdmLkjZH","XhEeRFbisz5SLRLws","EoffqxLuQbhKRpNmQ","rkJycSJQe7AoF5gKf","P5LkHJDQ7GXibcCon"]}